Tops & Flops Stocks
Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Zoetis Inc. A | 0.090% | 4.902% | 2.339% | -7.314% | -11.901% | 11.132% | 72.816% |
Biolife Solutions Inc | 1.220% | 1.235% | 2.500% | 1.863% | 10.067% | -35.433% | 7.036% |
Minerva Neurosciences Inc. | 0.900% | 5.310% | 2.586% | -56.048% | -59.212% | -84.091% | - |
Merck & Co. Inc. | 0.330% | 0.331% | 2.707% | 13.458% | 23.249% | 88.422% | 74.777% |
Forte Biosciences Inc. | -0.760% | -0.752% | 3.125% | -29.787% | 2.326% | -97.481% | - |
Veracyte Inc. | 4.080% | 4.813% | 3.158% | 0.513% | -24.031% | -46.448% | - |
Kura Oncology Inc | 0.550% | 4.943% | 3.168% | 90.248% | 50.117% | -9.363% | 36.898% |
Champions Oncology Inc | -4.270% | 4.000% | 3.540% | 0.862% | -2.905% | -42.927% | - |
Innoviva Inc. | -0.690% | - | 3.650% | 35.238% | -2.740% | 48.691% | - |
Neurocrine Bioscience | 2.930% | 3.260% | 3.702% | 50.509% | 11.526% | 77.684% | 86.188% |
Regeneron Pharmaceuticals Inc. | -0.400% | 8.074% | 3.749% | 30.470% | 13.129% | 121.127% | 212.180% |
Novavax Inc. | -0.560% | 5.391% | 4.593% | -38.703% | -4.121% | -97.037% | -41.676% |
Verastem Inc. | 8.820% | 29.070% | 4.717% | 128.282% | 47.020% | -60.436% | - |
Intra-Cellular Therapies Inc. | -1.500% | -1.481% | 4.724% | 18.327% | 1.994% | 149.812% | 428.617% |
Pfizer Inc. | -0.310% | 7.424% | 4.957% | -26.094% | -1.034% | -20.609% | -24.969% |
Viking Therapeutics Inc | 0.000% | -0.671% | 5.051% | 256.991% | 323.449% | 1449.278% | - |
Heron Therapeutics Inc. | 3.330% | 22.765% | 5.130% | 31.881% | 69.682% | -80.533% | - |
Celldex Therapeutics | -2.530% | 10.227% | 6.011% | 28.477% | 7.182% | 75.884% | 630.697% |
Achieve Life Sciences Inc. | 1.290% | 2.320% | 6.393% | -43.822% | 17.287% | -46.545% | - |
Anika Therapeutics | 0.780% | 5.785% | 6.667% | 9.402% | 25.490% | -24.260% | -28.412% |
Trevena Inc. | -0.690% | 4.949% | 7.292% | -34.928% | -40.998% | -98.917% | -98.928% |